Ulcus Cruris Clinical Trial
Official title:
Randomized, Double-blind, Single-center, Placebo-controlled Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds
This is a randomized, double-blind, placebo-controlled trial with octenisept® or placebo in patients with chronic leg ulcers. The study will be conducted at a single center with a total of 70 patients. Patients will be randomized to either the octenisept® group or to the placebo group.
Randomized, double-blind, placebo-controlled trial with octenisept® or placebo in patients
with chronic leg ulcers. The study will be conducted at a single center with a total of 70
patients. Patients will be randomized to either the octenisept® group or to the placebo
group.
Primary Objectives: Antimicrobial efficacy of octenisept® compared to placebo. Secondary
Objectives: Subjective tolerance of octenisept®, evaluation of wound parameters.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05890703 -
Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream
|
Phase 2 |